FDC’s Generics Cefixime Receives Approval in US
14 May 2026 //
FDA
Stira’s Generics L-Glutamine Receives Approval in US
14 May 2026 //
FDA
Chiesi Farmaceutici’s Trimbow Receives Approval in US
14 May 2026 //
FDA
Ionetix`s Gallium Ga-68 Gozetotide Receives US Approval
14 May 2026 //
FDA
Sandoz’s Generics Tivozanib Receives Tentative Approval in US
14 May 2026 //
FDA
Zydus’s Generics Ubrogepant Receives Tentative Approval in US
14 May 2026 //
FDA
Ionetix’s Generics Gallium Gozetotide Receives Approval in US
14 May 2026 //
FDA
Beone Medicines’ Beqalzi Receives Approval in US
13 May 2026 //
FDA
Tamarang Sa`s Sugammadex Receives Tentative US Approval
13 May 2026 //
FDA
Tamarang’s Generics Sugammadex Receives Tentative Approval in US
12 May 2026 //
FDA
Lupin’s Generics Famotidine Receives Approval in US
12 May 2026 //
FDA
Centaur Pharma`s Dapagliflozin Gets Tentative US Approval
12 May 2026 //
FDA
Umedica’s Generics Zolpidem Tartrate Receives Approval in US
12 May 2026 //
FDA
Sandoz’s Generics Bempedoic Acid Receives Tentative Nod in US
12 May 2026 //
FDA
Encube’s Generics Estradiol Receives Approval in US
11 May 2026 //
FDA
Mylan’s Generics Levetiracetam Receives Approval in US
08 May 2026 //
FDA
Inventia’s Generics Sitagliptin Receives Tentative Approval in US
07 May 2026 //
FDA
I3 Pharms’ Generics Paliperidone Receives Approval in US
07 May 2026 //
FDA
Accord Biopharma’s Biologics Ennumo Receives Approval in US
07 May 2026 //
FDA
Zydus’ Generics Hydrocortisone Sodium Receives Approval in US
07 May 2026 //
FDA
Micro’s Generics Brimonidine Tartrate Receives Approval in US
07 May 2026 //
FDA
Lachman’s Dolutegravir, Lamivudin Receives Tentative Nod in US
07 May 2026 //
FDA
Dr. Reddy’s Generics Empagliflozin Receives Tentative Nod in US
07 May 2026 //
FDA
Sandoz’s Generics Vasopressin Receives Approval in US
06 May 2026 //
FDA
Centaur’s Generics Dapagliflozin Receives Tentative Nod in US
06 May 2026 //
FDA
Zhejiang Novous’s Generics Voriconazole Receives Approval in US
05 May 2026 //
FDA
Caplin’s Generics Calcium Gluconate Receives Approval in US
04 May 2026 //
FDA
Yichang Humanwell’s Generics Bupropion Receives Approval in US
04 May 2026 //
FDA
Ipca’s Generics Propranolol HCl Receives Approval in US
01 May 2026 //
FDA
Incyte Oration’s Jakafi Xr Receives Approval in US
01 May 2026 //
FDA
Micro’s Generics Torsemide Receives Approval in US
01 May 2026 //
FDA
Bicoon’s Generics Sitagliptin Receives Tentative Approval in US
01 May 2026 //
FDA
Arvinas Operations’ Veppanu Receives Approval in US
01 May 2026 //
FDA
Deva Holding’ Generics Mirabegron Receives Approval in US
01 May 2026 //
FDA
Apotex’s Evdi Receives Approval in US
01 May 2026 //
FDA
Hetero’s Generics Sodium Sulfate Receives Tentative Nod in US
01 May 2026 //
FDA
Sun Pharma Canada’s Generics Doxepin HCl Receives Approval in US
28 Apr 2026 //
FDA
Aizant’s Generics Eltrombopag Olamine Receives Approval in US
28 Apr 2026 //
FDA
Micro’s Generics Ticagrelor Receives Approval in US
27 Apr 2026 //
FDA
Alembic’s Generics Fingolimod HCl Receives Approval in US
24 Apr 2026 //
FDA
Astrazeneca’s Biologics Saphnelo Receives Approval in US
24 Apr 2026 //
FDA
ScieGen Pharms’ Generics Valsartan Receives Approval in US
23 Apr 2026 //
FDA
Teva’ Generics Budesonide & Formoterol Receives Approval in US
23 Apr 2026 //
FDA
Navinta’s Generics Glycerol Phenylbutyrate Receive Approval in US
23 Apr 2026 //
FDA
Hainan’s Generics Tigecycline Receives Tentative Approval in US
23 Apr 2026 //
FDA
Cipla’s Generics Albuterol Sulfate Receives Approval in US
22 Apr 2026 //
FDA
Micro’s Generics Escitalopram Oxalate Receives Approval in US
22 Apr 2026 //
FDA
Omsav Pharma’s Generics Flecainide Receives Approval in US
22 Apr 2026 //
FDA
Shuangcheng’s Generics Pantoprazole Na Receives Approval in US
22 Apr 2026 //
FDA
Anthea Pharma’s Generics Bupivacaine HCl Receives Approval in US
22 Apr 2026 //
FDA
Apotex’s Generics Multiple Vitamins Inj Receives Approval in US
21 Apr 2026 //
FDA
Laurus’s Generics Valsartan Receives Approval in US
21 Apr 2026 //
FDA
Aurobindo Pharma’s Generics Canagliflozin Receives Approval in US
20 Apr 2026 //
FDA
Aurobindo Pharma’s Generics Pirfenidone Receives Approval in US
20 Apr 2026 //
FDA
Sandoz’s Generics Enzalutamide Receives Approval in US
20 Apr 2026 //
FDA
Merck Sharp And Dohme’s Idvynso Receives Approval in US
20 Apr 2026 //
FDA
Torrent’s Generics Vericiguat Receives Tentative Approval in US
20 Apr 2026 //
FDA
Extrovis’ Generics Na Acetate Receives Approval in US
17 Apr 2026 //
FDA
Hetero’s Generics Ibrutinib Receives Tentative Approval in US
16 Apr 2026 //
FDA
Mankind’s Generics Brimonidine Tartrate Receives Approval in US
16 Apr 2026 //
FDA
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.